Skip to main content
Top

International Journal of Hematology

Issue 2/2006

Content (15 Articles)

New Insight into the Molecular Basis of Hemophilia A

Johannes Oldenburg, Osman El-Maarri

Glucose-6-Phosphate Dehydrogenase Variants Associated with Favism in Thai Children

Vichai Laosombat, Benjamas Sattayasevana, Teerachit Chotsampancharoen, Malai Wongchanchailert

Case Report

Identification of a Novel Mutation Combination in Factor XIII Deficiency: Genetic Update to the First Reported Case in the United States

Amy Halverstadt, Sean Walsh, Stephen M. Roth, Robert E. Ferrell, James M. Hagberg

Case Report

Chronic Eosinophilic Leukemia with the FIP1L1-PDGFR± Fusion Gene in a Patient with a History of Combination Chemotherapy

Yasuhiro Tanaka, Masayuki Kurata, Katsuhiro Togami, Haruyuki Fujita, Naoko Watanabe, Akiko Matsushita, Akinori Maeda, Kenichi Nagai, Akiko Sada, Toshimitsu Matsui, Takayuki Takahashi

Case Report

Successful Reduced-Intensity Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome with Severe Coronary Artery Disease

Shigeki Kosugi, Makoto Hirokawa, Yoshinari Kawabata, Hitoshi Hasegawa, Tomoko Yoshioka, Ikuo Miura, Ken-ichi Sawada

Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan

Masahiro Imamura, Shigetaka Asano, Mine Harada, Yasuo Ikeda, Koji Kato, Shunichi Kato, Keisei Kawa, Seiji Kojima, Yasuo Morishima, Yoshihisa Morishita, Tatsutoshi Nakahata, Jun Okamura, Shinichiro Okamoto, Shintaro Shiobara, Mitsune Tanimoto, Masahiro Tsuchida, Yoshiko Atsuta, Kazuhito Yamamoto, Junji Tanaka, Nobuyuki Hamajima, Yoshihisa Kodera

Letter to the Editor

Marked Spherocytosis in Clostridal Sepsis

Tetsuo Shoda, Minoru Yoshimura, Daishi Hayata, Yoshio Miyazawa, Kiyoyuki Ogata

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine